November 9-11, 2020 | Virtual Conference

Speakers

Laura Pethick, PharmD, MBA

Director, Patient Safety
Tolmar Pharmaceuticals, Inc.

Laura Pethick, PharmD, MBA is the Director of Patient Safety at Tolmar Inc. and has been working in the pharmaceutical industry for over 25 years specializing in pharmacovigilance, risk management, service provider selection and management, Risk Evaluation and Mitigation Strategies (REMS), Technical Quality Complaints, pregnancy registries, and drug information. Laura has spent 18 years in Patient Safety and Risk Management. Laura graduated from pharmacy school in 1996 with a bachelors in pharmacy, with her Doctorate in Pharmacy in 2011 and with an MBA in 2017. Laura is currently responsible for global and local Pharmacovigilance and all Technical Quality Complaints reported for all Tolmar products. Current pharmacovigilance responsibilities includes oversight of the service provider conducting collection, analysis, and reporting of adverse reactions received, literature review, periodic reporting, and evaluating potential signals and safety label updates. Laura is determined, collaborative and passionate about Patient Safety.

Get Started + Register

Whether you are an AAM member, general attendee, speaker or exhibitor, you can be part of the premier scientific and regulatory conference for the U.S. generics and biosimilars industry.

Get Started + Register

Whether you are an AAM member, general attendee, speaker or exhibitor, you can be part of the premier scientific and regulatory conference for the U.S. generics and biosimilars industry.

Skip to content